Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Intercellular labeling of ligand-receptor interactions

a technology of ligand receptor and intercellular labeling, which is applied in the field of immune system, can solve the problems of inability to achieve effective determination and tracking of these interactions in the context of living animals, and achieve the effect of facilitating purification and isolation

Inactive Publication Date: 2018-12-06
WHITEHEAD INST FOR BIOMEDICAL RES
View PDF0 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a method for labeling cells with different polypeptides using a sortase enzyme. This can be useful for identifying and isolating specific cells or polypeptides. The technique involves using a receptor-ligand pair, such as CD40 and CD40L, to attach a peptide to a cell surface. The polypeptide can also contain a protein tag for easier purification. Overall, this method allows for the efficient and accurate identification of cells and polypeptides.

Problems solved by technology

This gap is due largely to the fact that there is no effective way to determine the extent to which two cells have interacted within a living animal.
Interactions between different ligand-receptor pairs expressed by various subsets of immune cells are key events in the immune response, but the tracking of these interactions in the context of a living animal has never been achieved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Intercellular labeling of ligand-receptor interactions
  • Intercellular labeling of ligand-receptor interactions
  • Intercellular labeling of ligand-receptor interactions

Examples

Experimental program
Comparison scheme
Effect test

example 1

ular Labeling Mediated by CD40 / CD40L Interaction

[0185]To track intercellular interactions between ligand and receptor molecules expressed at the plasma membrane of cells, ligand and receptor pairs were engineered by genetic fusion so that one of the interacting partner expressed S. aureus SortaseA (SrtA) enzyme at its extracellular portion and the other one presented 5 extracellular N-terminal glycine residues (FIG. 1A). A triple mutated version of SrtA enzyme (P94S-D160N-K196T) with improved catalytic properties as described by Chen et al. PNAS, 2011 (FIG. 1B) was employed. Upon ligand-receptor interaction, and in presence of a biotinylatated or fluorescently labeled SrtA substrate as the short peptide LPETG (SEQ ID NO: 2), spatial proximity allows the labeled substrate to be transferred from the SrtA-engineered ligand to the N-terminus glycine of the receptor.

[0186]Briefly, expression vectors carrying G5-myc-CD40 and CD40L-SrtA fusion proteins as shown in FIG. 2A were constructed ...

example 2

ular Labeling Mediated by Various Ligand-Receptor Pair Interaction

[0190]Intercellular labeling mediated by additional ligand-receptor pair interaction (including CD28 / CD80, CTLA4 / CD80, CD28 / CD86, CTLA4 / CD86, PD-1 / PD-L1, PD-1 / PD-L2, and ICOS / ICOSL) was examined following the method described in Example 1 above.

[0191]Constructs for expressing the ligand / receptor fusion proteins are illustrated in FIG. 4A. These expression vectors were transfected into HEK293T cells. Cells expressing G5-containing fusion proteins were included with cells expressing the corresponding interaction partner-Srt fusion proteins min in presence of a biotin-LPETGG (SEQ ID NO: 5) peptide. The cells were then washed, stained with Streptavidin and analyzed by flow cytometry. As shown in FIGS. 4B and 4C. A strong labeling of G5-expressing cells was observed when incubated with cells expressing the interacting partner. These results further demonstrate that the cell labelled was mediated by receptor-ligand interact...

example 3

ular Labeling in Primary Murine Lymphocytes

[0192]Intercellular labeling was also tested in primary murine B and T lymphocytes overexpressing SrtA / G5 tagged constructs (FIG. 7). As observed in HEK293T cells, intercellular labeling of G5-CD40 expressing B cells occurs efficiently upon interaction with CD4+T OT-II cells overexpressing CD40L-SrtA, but it is present at a very low level when SrtA-PDGFR is used. When OT-II peptide is added to the co-culture, intercellular labeling is efficiently achieved with both CD40L-SrtA and SrtA-PDGFR expressing CD4+ T cells, indicating that cognate interaction can be tracked also using non interacting molecules (i.e., SrtA-PDFGR).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An sortase-mediated intercellular labeling method allowing for tracking ligand-receptor interaction both in vitro and in vivo; and uses thereof for tracking molecule interactions both in vitro and in vivo, identifying modulators of ligand-receptor interaction, identifying potential binding partners of a protein of interest, identifying B cells expressing high affinity B cell receptors to antigens, and identifying the antigen to which a T cell of interest binds.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]This application is a divisional of and claims priority under 35 U.S.C. § 120 to U.S. application Ser. No. 14 / 875,140, filed Oct. 5, 2015, which claims the benefit of the filing date of U.S. Provisional Application No. 62 / 059,452, filed Oct. 3, 2014, the entire contents of which are incorporated by reference herein.GOVERNMENT SUPPORT[0002]This invention was made with Government support under Grant No. 1DP5OD01214601, awarded by the National Institutes of Health. The Government has certain rights in this invention.BACKGROUND OF THE INVENTION[0003]One of the key characteristics of the immune system is the ability to react to pathogens by generating antibodies. An effective immune response requires the production of antibodies that bind antigens with high affinity and specificity. Exposure to antigen triggers the generation and clonal selection of B cells carrying novel mutant Ig sequences with improved antigen affinity, in a phenomenon know...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12N9/52A01K67/027G01N33/50
CPCG01N2333/70578C12Y304/2207C12N9/52A01K67/027C07K2319/70G01N2333/70532A01K67/0275G01N33/5008A01K2267/0387A01K2267/03A01K2227/105A01K2217/072G01N33/5047
Inventor PASQUAL, GIULIAVICTORA, GABRIEL
Owner WHITEHEAD INST FOR BIOMEDICAL RES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com